Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2021 Filed Mar 23, 2021 00:57 UTC |
Roberts ZacharyChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 240,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-21-022479 · doc4.xml · derivative · entry 1 Roberts Zachary · CIK 0001851044 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:50 UTC |
Crouch BronsonDirector · CEO and Chairman · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 1,200,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-21-022472 · doc4.xml · derivative · entry 1 Crouch Bronson · CIK 0001851041 · Director · CEO and Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200,000 Underlying: Common Stock · 1,200,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:58 UTC |
Shah Nimish PDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022480 · doc4.xml · derivative · entry 1 Shah Nimish P · CIK 0001698082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2031-03-18 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date. F2 · ownership.direct: The Reporting Person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the Reporting Person and the Management Company, the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:55 UTC |
McGaughy R Kent JrDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022476 · doc4.xml · derivative · entry 1 McGaughy R Kent Jr · CIK 0001402856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2031-03-18 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:51 UTC |
Gibson Neil WDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022473 · doc4.xml · derivative · entry 1 Gibson Neil W · CIK 0001555918 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2031-03-18 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:56 UTC |
Nielsen JackDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022477 · doc4.xml · derivative · entry 1 Nielsen Jack · CIK 0001602402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2031-03-18 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:53 UTC |
Laumas SandeepCFO and CBO
|
GrantEmployee Stock Option (right to buy) · Derivative | 240,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001209191-21-022474 · doc4.xml · derivative · entry 1 Laumas Sandeep · CIK 0001721664 · CFO and CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Common Stock · 240,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 18, 2021 Filed Mar 23, 2021 00:47 UTC |
Binder GwendolynDirector
|
GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022470 · doc4.xml · derivative · entry 1 Binder Gwendolyn · CIK 0001791742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Common Stock · 52,000 shares Expires 2031-03-18 F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.